SEC Form 4 · accession 0001171843-17-003745
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garen G Bohlin
Director
Period of report
Jun 20, 2017
Accepted (ET)
Jun 21, 2017 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.30 | Jun 20, 2017 | A | 6,666 | A | — | Jun 19, 2027 | Common Stock, $0.001 par value | 6,666 | 6,666 | D |
Explanation of responses
- F1The options were granted on June 20, 2017 and the shares underlying this option will vest 100% at the earlier of (i) June 20, 2018 and (ii) the Issuer's next annual meeting of stockholders.